Literatur
Eberhardt WE, Mitchell A, Crowley J et al (2015) The IASLC lung cancer staging project: Proposals for the revision of the M Descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10:1515–1522
Golden EB, Demaria S, Schiff PB et al (2013) An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 1:365–372
Gomez DR, Blumenschein GR Jr, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:1672–1682
Rusthoven KE, Hammerman SF, Kavanagh BD et al (2009) Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol 48:578–583
Tönnies S, Tönnies M, Kollmeier J et al (2016) Impact of preoperative 18 F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer. Lung Cancer 93:28–34
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Walles gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
J. Schreiber, Magdeburg
P. Zabel, Lübeck/Borstel
Rights and permissions
About this article
Cite this article
Walles, T. Lokalablative Therapie beim oligometastasierten nicht-kleinzelligen Bronchialkarzinom. Pneumologe 14, 371–373 (2017). https://doi.org/10.1007/s10405-017-0139-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-017-0139-5